Literature DB >> 22989833

Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy.

Yoshinori Sato1, Shinichiro Tsunoda, Tsuyoshi Nozue, Qinya Pan, Harue Wakasugi, Ashio Yoshimura.   

Abstract

We herein report three cases of Nephrotic Syndrome (NS) with idiopathic membranous nephropathy (IMN) in which the patients were resistant to steroid (PSL) and cyclosporine (CyA) therapy. All three patients had a high risk of renal failure because of persistently high levels of proteinuria. We performed low-density lipoprotein apheresis (LDL-A) and achieved complete remission in two cases. The third patients developed NS relapse and a deteriorating renal function; however, withdrawal from dialysis therapy was achieved. There are no proven therapies for treating patients with PSL- and CyA-resistant IMN with acute deteriorating renal function or difficulties in maintaining fluid balance. We evaluated the treatment course and physiological mechanisms and reviewed similar cases in the pertinent literature.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989833     DOI: 10.2169/internalmedicine.51.7204

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  5 in total

Review 1.  An update on LDL apheresis for nephrotic syndrome.

Authors:  Rupesh Raina; Vinod Krishnappa
Journal:  Pediatr Nephrol       Date:  2018-09-14       Impact factor: 3.714

2.  Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.

Authors:  Yoko Nishizawa; Kazuho Honda; Yumi Aoyama; Yumi Hosoda; Tomomi Tamura; Ai Horimoto; Kiyotsugu Omae; Chieko Higuchi; Hiroshi Sakura; Kosaku Nitta; Tetsuya Ogawa
Journal:  CEN Case Rep       Date:  2020-06-16

3.  Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.

Authors:  Eri Muso; Masatoshi Mune; Tsutomu Hirano; Motoshi Hattori; Kenjiro Kimura; Tsuyoshi Watanabe; Hitoshi Yokoyama; Hiroshi Sato; Shunya Uchida; Takashi Wada; Tetsuo Shoji; Yukio Yuzawa; Tsukasa Takemura; Satoshi Sugiyama; Yoshiki Nishizawa; Satoru Ogahara; Noriaki Yorioka; Soichi Sakai; Yosuke Ogura; Susumu Yukawa; Yasuhiko Iino; Enyu Imai; Seiichi Matsuo; Takao Saito
Journal:  Clin Exp Nephrol       Date:  2014-06-17       Impact factor: 2.801

4.  Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis.

Authors:  Junko Yabuuchi; Tatsuya Suwabe; Hiroki Mizuno; Toshiharu Ueno; Junichi Hoshino; Akinari Sekine; Masahiro Kawada; Masayuki Yamanouchi; Noriko Hayami; Rikako Hiramatsu; Eiko Hasegawa; Naoki Sawa; Kenmei Takaichi; Takeshi Fujii; Kenichi Ohashi; Yoshifumi Ubara
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

5.  A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.

Authors:  Eri Muso; Masatoshi Mune; Tsutomu Hirano; Motoshi Hattori; Kenjiro Kimura; Tsuyoshi Watanabe; Hitoshi Yokoyama; Hiroshi Sato; Shunya Uchida; Takashi Wada; Tetsuo Shoji; Tsukasa Takemura; Yukio Yuzawa; Satoru Ogahara; Satoshi Sugiyama; Yasuhiko Iino; Soichi Sakai; Yousuke Ogura; Susumu Yukawa; Yoshiki Nishizawa; Noriaki Yorioka; Enyu Imai; Seiichi Matsuo; Takao Saito
Journal:  Nephron Extra       Date:  2015-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.